CH490087A - Verfahren zur Herstellung von stabilen, für die parenterale, perorale und lokale Verabreichung geeigneten wässrigen Oxytetracyclinlösungen - Google Patents

Verfahren zur Herstellung von stabilen, für die parenterale, perorale und lokale Verabreichung geeigneten wässrigen Oxytetracyclinlösungen

Info

Publication number
CH490087A
CH490087A CH766867A CH766867A CH490087A CH 490087 A CH490087 A CH 490087A CH 766867 A CH766867 A CH 766867A CH 766867 A CH766867 A CH 766867A CH 490087 A CH490087 A CH 490087A
Authority
CH
Switzerland
Prior art keywords
peroral
parenteral
preparation
local administration
stable aqueous
Prior art date
Application number
CH766867A
Other languages
English (en)
Original Assignee
Koninklijke Gist Spiritus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Gist Spiritus filed Critical Koninklijke Gist Spiritus
Publication of CH490087A publication Critical patent/CH490087A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH766867A 1966-05-31 1967-05-31 Verfahren zur Herstellung von stabilen, für die parenterale, perorale und lokale Verabreichung geeigneten wässrigen Oxytetracyclinlösungen CH490087A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (de) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
CH490087A true CH490087A (de) 1970-05-15

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
CH766867A CH490087A (de) 1966-05-31 1967-05-31 Verfahren zur Herstellung von stabilen, für die parenterale, perorale und lokale Verabreichung geeigneten wässrigen Oxytetracyclinlösungen

Country Status (22)

Country Link
US (1) US3557280A (de)
JP (1) JPS5010373B1 (de)
AT (1) AT272522B (de)
BE (1) BE699091A (de)
CH (1) CH490087A (de)
CS (1) CS151454B2 (de)
DE (1) DE1617576C3 (de)
DK (1) DK117587B (de)
ES (1) ES340956A1 (de)
FI (1) FI43622B (de)
FR (1) FR5953M (de)
GB (1) GB1131007A (de)
GR (1) GR33861B (de)
IL (1) IL28009A (de)
IT (1) IT1140250B (de)
LU (1) LU53788A1 (de)
MY (1) MY7100015A (de)
NL (1) NL6607516A (de)
NO (1) NO126298B (de)
SE (1) SE354417B (de)
SU (1) SU510986A3 (de)
YU (1) YU31326B (de)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (de) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
CN102336680A (zh) 1999-09-14 2012-02-01 塔夫茨大学信托人 用基于过渡金属的化学制备取代四环素的方法
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
AU3105801A (en) 2000-01-24 2001-07-31 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
WO2001074761A1 (en) * 2000-03-31 2001-10-11 Trustees Of Tufts College 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
CA2409063A1 (en) 2000-05-15 2001-11-22 Mark L. Nelson 7-substituted fused ring tetracycline compounds
WO2001098236A2 (en) * 2000-06-16 2001-12-27 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
CN102336679A (zh) 2000-07-07 2012-02-01 塔夫茨大学信托人 7-取代的四环素化合物
US7094806B2 (en) 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
AU2001271556A1 (en) 2000-07-07 2002-01-21 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
WO2002004405A2 (en) 2000-07-07 2002-01-17 Trustees Of Tufts College 13-substituted methacycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
KR100699390B1 (ko) 2000-07-07 2007-03-28 트러스티즈 오브 터프츠 칼리지 9-치환된 미노사이클린 화합물
MXPA03008165A (es) 2001-03-13 2003-12-12 Paratek Pharm Innc Compuestos tetraciclina sustituidos en la posicion 7,9.
WO2002072506A2 (en) * 2001-03-13 2002-09-19 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
WO2002072031A2 (en) 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
US6841546B2 (en) * 2001-03-14 2005-01-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
EP1399414B1 (de) 2001-04-24 2010-01-13 Paratek Pharmaceuticals, Inc. Substituierte tetracyclin-verbindungen zur behandlung von malaria
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP1474380A4 (de) 2002-01-08 2007-04-18 Paratek Pharm Innc 4-desdimethyl amino tetra cyclin verbindungen
EA200802365A1 (ru) 2002-03-08 2009-08-28 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
EP1503981A4 (de) 2002-03-21 2007-08-15 Paratek Pharm Innc Substituierte tetracyclinverbindungen
EP1534300A4 (de) 2002-07-12 2008-04-23 Paratek Pharm Innc 3, 10, und 12a substituierte tetracyclin-verbindungen
EP2277504A1 (de) 2002-10-24 2011-01-26 Paratek Pharmaceuticals, Inc. Substituierte Tetracyclin-Verbindungen zur Behandlung von Malaria
JP2006514119A (ja) * 2003-02-12 2006-04-27 アール アンド ピー コリア カンパニー リミテッド 溶解率が向上した難溶性薬剤の溶媒系
AU2004259661B2 (en) 2003-07-09 2011-11-10 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
JP4733028B2 (ja) 2003-07-09 2011-07-27 パラテック ファーマシューティカルズ インコーポレイテッド 置換テトラサイクリン化合物
EP1716101A1 (de) * 2004-01-15 2006-11-02 Paratek Pharmaceuticals, Inc. Derivate von tetracyclinverbindungen mit aromatischem a-ring
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP1805134B1 (de) * 2004-10-25 2012-06-20 Paratek Pharmaceuticals, Inc. 4-aminotetracycline und verfahren zu ihrer verwendung
EP2949644A3 (de) 2004-10-25 2016-04-20 Paratek Pharmaceuticals, Inc. Substituierte tetracyclin-verbindungen
US8088755B2 (en) * 2005-02-04 2012-01-03 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
EP1910273A2 (de) * 2005-07-21 2008-04-16 Paratek Pharmaceuticals, Inc. 10-substituierte tetracycline und verfahren zuderen herstellung
EP1926481A2 (de) * 2005-09-19 2008-06-04 Albermarle Corporation Hochkonzentrierte giessbare wässrige lösungen von kalium-ibuprofen, ihre herstellung und verwendung
JP2009524675A (ja) * 2006-01-24 2009-07-02 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリンの経口バイオアベイラビリティーを増加する方法
US20070244335A1 (en) * 2006-04-17 2007-10-18 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
ES2528202T3 (es) * 2006-04-24 2015-02-05 Teva Pharmaceutical Industries Ltd. Una forma cristalina de tigeciclina y procesos para su preparación
JP2009537139A (ja) * 2006-05-15 2009-10-29 パラテック ファーマシューティカルズ インコーポレイテッド 置換されたテトラサイクリン化合物を用いて、遺伝子または遺伝子産物の発現を制御する方法
US8440646B1 (en) 2006-10-11 2013-05-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of Bacillus anthracis infections
CA2892739A1 (en) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
MX2009006846A (es) 2006-12-21 2009-08-20 Paratek Pharm Innc Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
AU2008239606A1 (en) * 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
JP2010525069A (ja) 2007-04-27 2010-07-22 パラテック ファーマシューティカルズ インコーポレイテッド アミノアルキルテトラサイクリン化合物の合成方法および精製方法
CN101784517A (zh) 2007-07-06 2010-07-21 帕拉特克药品公司 合成取代的四环素化合物的方法
WO2009111064A2 (en) 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
JP2011517697A (ja) * 2008-04-14 2011-06-16 パラテック ファーマシューティカルズ インコーポレイテッド 置換テトラサイクリン化合物
TW202021946A (zh) * 2008-05-23 2020-06-16 美商派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
BRPI0916344A2 (pt) * 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2010033939A1 (en) * 2008-09-19 2010-03-25 Paratek Pharmaceuticals, Inc. Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
DE202010018378U1 (de) 2009-04-10 2016-04-07 Tufts Medical Center, Inc. PAR-1-Aktivierung durch Metalloproteinase-1 (MMP-1)
ES2739626T3 (es) 2011-05-12 2020-02-03 Paratek Pharm Innc Sales cristalinas de amida del ácido (4S,4aS,5aR,12aS)-4-dimetilamino-3,10,12,12a-tetrahidroxi-7-[(metoxi(metil)amino)-metil]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahidro-naftacen-2-carboxílico y métodos de uso de las mismas
US10383884B2 (en) 2016-11-01 2019-08-20 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)
US20200222432A1 (en) 2017-07-21 2020-07-16 Almirall, Llc. Treatment of non-inflammatory lesions

Also Published As

Publication number Publication date
DK117587B (da) 1970-05-11
MY7100015A (en) 1971-12-31
ES340956A1 (es) 1968-06-16
DE1617576A1 (de) 1972-04-27
DE1617576B2 (de) 1980-04-10
YU31326B (en) 1973-04-30
AT272522B (de) 1969-07-10
CS151454B2 (de) 1973-10-19
FR5953M (de) 1968-04-16
BE699091A (de) 1967-11-27
IL28009A (en) 1970-08-19
DE1617576C3 (de) 1980-12-11
FI43622B (de) 1971-02-01
SE354417B (de) 1973-03-12
NO126298B (de) 1973-01-22
JPS5010373B1 (de) 1975-04-21
US3557280A (en) 1971-01-19
GB1131007A (en) 1968-10-16
GR33861B (el) 1968-02-09
NL6607516A (de) 1967-12-01
LU53788A1 (de) 1967-07-31
SU510986A3 (ru) 1976-04-15
IT1140250B (it) 1986-09-24

Similar Documents

Publication Publication Date Title
CH490087A (de) Verfahren zur Herstellung von stabilen, für die parenterale, perorale und lokale Verabreichung geeigneten wässrigen Oxytetracyclinlösungen
AT294853B (de) Verfahren zur Herstellung von neuen Polysaccharidderivaten
CH494222A (de) Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
CH507200A (de) Verfahren zur Herstellung von 3,4-Dihydroxyphenylalkanolaminen
CH522671A (de) Verfahren zur Herstellung von 3,1-Benzoxazin-Derivaten
AT269855B (de) Verfahren zur Herstellung von neuen 5-Nitrofuran- bzw. 5-Nitrothiopen-Derivaten
CH495348A (de) Verfahren zur Herstellung von a-Oxo-a, B-seco-steroid-B(y)-inen
CH490300A (de) Verfahren zur Herstellung von 3,5-Dimethylphenol
AT272527B (de) Verfahren zur Herstellung von neuen Derivaten des Proscillaridin A
AT275758B (de) Verfahren zur Herstellung von neuen 4-Oxa-9β,10α-Steroiden
AT283356B (de) Verfahren zur Herstellung von neuen 1,2,4-Oxdiazolidin-Derivaten
CH540896A (de) Verfahren zur Herstellung von 15,16B-Methylensteroiden
CH558810A (de) Verfahren zur herstellung von neuen cephalosporinen und deren saeurederivaten.
AT277240B (de) Verfahren zur Herstellung von 6-Styryl-5,6-dihydro-α-pyronen
CH489525A (de) Verfahren zur Herstellung von 1,8-Naphthyridinderivaten
CH491863A (de) Verfahren zur Herstellung von neuen Diphenylamin-Derivaten
CH521361A (de) Verfahren zur Herstellung von neuen 11-Amino-5,6-dihydro-6-morphanthridonen
CH538459A (de) Verfahren zur Herstellung von in 3-Stellung unsubstituierten 1,4-Steroiden
CH497411A (de) Verfahren zur Herstellung von neuen Homogonan-Derivaten
CH498118A (de) Verfahren zur Herstellung von 2-Amidino-1,2,3,4-tetrahydroisochinolinen
CH483434A (de) Verfahren zur Herstellung von 1,2-Dihydrobenzodiazepinen
CH523275A (de) Verfahren zur Herstellung von 3,1-Benzothiazin-Derivaten
CH490399A (de) Verfahren zur Herstellung von 1,4-Benzodiazepinderivaten
CH532573A (de) Verfahren zur Herstellung von 4-cis-Cyclohexan-1,2-dicarboximiden
CH478837A (de) Verfahren zur Herstellung von neuen Thioxanthen-10,10-dioxid-Derivaten

Legal Events

Date Code Title Description
PL Patent ceased